Optimal Hospice Care 3461 Brookside Road, Suite A-2, Stockton, CA, 95219 | |
(209) 670-8000 |
News Archive
A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.
Monographs addressing individual mandates, tax exclusion and a public plan option were released today by the American College of Physicians (ACP).
A budget plan to save money by moving thousands of children into the Medicaid program is scrutinized while legislators scramble to draft companion legislation to implement the budget.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
A retrospective study of nearly 9800 women with breast cancer who participated in randomized clinical trials was presented today at the 2019 San Antonio Breast Cancer Symposium.
› Verified 3 days ago
Name | Optimal Hospice Care |
---|---|
Location | 3461 Brookside Road, Suite A-2, Stockton, California |
Hospice ID | 051793 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
SSA county code | 490 |
News Archive
A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.
Monographs addressing individual mandates, tax exclusion and a public plan option were released today by the American College of Physicians (ACP).
A budget plan to save money by moving thousands of children into the Medicaid program is scrutinized while legislators scramble to draft companion legislation to implement the budget.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
A retrospective study of nearly 9800 women with breast cancer who participated in randomized clinical trials was presented today at the 2019 San Antonio Breast Cancer Symposium.
› Verified 3 days ago
NPI Number | 1821166745 |
Organization Name | Optimal Hospice, Inc. |
Address | 3461 Brookside Rd Ste A-2 Stockton, California, 95219 |
Phone Number | (209)338-3000 |
News Archive
A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.
Monographs addressing individual mandates, tax exclusion and a public plan option were released today by the American College of Physicians (ACP).
A budget plan to save money by moving thousands of children into the Medicaid program is scrutinized while legislators scramble to draft companion legislation to implement the budget.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
A retrospective study of nearly 9800 women with breast cancer who participated in randomized clinical trials was presented today at the 2019 San Antonio Breast Cancer Symposium.
› Verified 3 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.8 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 98.4 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 84.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.8 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 95.5 | 93.3 |
News Archive
A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.
Monographs addressing individual mandates, tax exclusion and a public plan option were released today by the American College of Physicians (ACP).
A budget plan to save money by moving thousands of children into the Medicaid program is scrutinized while legislators scramble to draft companion legislation to implement the budget.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
A retrospective study of nearly 9800 women with breast cancer who participated in randomized clinical trials was presented today at the 2019 San Antonio Breast Cancer Symposium.
› Verified 3 days ago
Home Health Aides | 15 |
Counselors | 5 |
Licensed Practical or Vocational Nurses | 11.5 |
Medical Social Workers | 6.7 |
Registered Nurses | 19 |
Other Personnel | 15.5 |
Total Employees | 72.7 |
---|
News Archive
A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.
Monographs addressing individual mandates, tax exclusion and a public plan option were released today by the American College of Physicians (ACP).
A budget plan to save money by moving thousands of children into the Medicaid program is scrutinized while legislators scramble to draft companion legislation to implement the budget.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
A retrospective study of nearly 9800 women with breast cancer who participated in randomized clinical trials was presented today at the 2019 San Antonio Breast Cancer Symposium.
› Verified 3 days ago
Hospice Of San Joaquin Location: 3888 Pacific Avenue, Stockton, California, 95204 Phone: (209) 670-8000 |
Aseracare Hospice Location: 2529 W March Lane, Suite 101, Stockton, California, 95207 Phone: (209) 670-8000 |
Optimal Hospice Care Location: 3461 Brookside Road, Suite A-2, Stockton, California, 95219 Phone: (209) 670-8000 |
Bristol Hospice - Stockton, Llc Location: 5757 Pacific Avenue, Suite 228, Stockton, California, 95207 Phone: (209) 670-8000 |